ConditionsDrug OverdoseMetforminDapagliflozinLactic AcidosisDiabetic KetoacidosisIntensive Care Units
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Saint-Denis
About this trial
This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Admission to an intensive care unit (ICU) due to acute drug poisoning
Metformin alone
Metformin in combination with dapagliflozin
Disqualifiers
Patients under 18 years of age
No exposure to metformin
Exposure to dapagliflozin without metformin
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov